P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases

Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.033
https://www.valueinhealthjournal.com/article/S1098-3015(23)00133-X/fulltext
Section Title :
Section Order : 11651
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00133-X&doi=10.1016/j.jval.2023.03.033
HEOR Topics :
Tags :
Regions :